Nyblade Laura C
International Center for Research on Women (ICRW), Washington, DC 20036, USA.
Psychol Health Med. 2006 Aug;11(3):335-45. doi: 10.1080/13548500600595178.
The growing recognition of the reduction of HIV stigma as central to effective programs across the HIV/AIDS prevention to care and treatment continuum is leading to an increasing number of programs focused on stigma reduction. Correctly evaluating the impact of these programs depends on having a good set of measures that effectively capture and distinguish the complexities of HIV stigma. This paper reviews the existing literature on HIV stigma measurement and identifies key gaps that remain. There is a need for measures at the general population level that are unambiguous about the cause of the stigmatizing behavior, that capture enacted stigma (discrimination), and that can distinguish compound (layered) stigma. In addition, studies are needed in a wider variety of contexts and on a larger scale that include a comprehensive set of measures to capture the complexity of HIV-related stigma and ensure appropriate evaluation of stigma-reduction programs.
越来越多的人认识到,减少对艾滋病病毒的污名化是艾滋病病毒/艾滋病预防、护理和治疗连续统一体中有效项目的核心,这导致越来越多的项目专注于减少污名化。正确评估这些项目的影响取决于拥有一套有效的措施,以有效捕捉和区分艾滋病病毒污名化的复杂性。本文回顾了关于艾滋病病毒污名化测量的现有文献,并指出了仍然存在的关键差距。需要在一般人群层面上制定一些措施,这些措施要明确污名化行为的原因,要捕捉到实际发生的污名化(歧视),并且能够区分复合(分层)污名。此外,还需要在更广泛的背景下进行更大规模的研究,这些研究要包括一套全面的措施,以捕捉与艾滋病病毒相关污名化的复杂性,并确保对减少污名化项目进行适当评估。